MedPath

MS-Komplextreatment Benefit Study

Recruiting
Conditions
RRMS, SPMS, PPMS and the benefit of intensive treatment, especially of cognition.
Registration Number
DRKS00032034
Lead Sponsor
GZG-Meisenheim
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Multiple sclerosis

Exclusion Criteria

lack of consent

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in cognition, quality of life, depression, fatigue, walking distance, reduction in spasticity after two weeks of complex MS treatment.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath